Boston University
Role of aortic carboxypeptidase-like protein in adipose tissue fibrosis
Abstract
dc:description.abstractObesity is a growing global health concern, with prevalence rates more than doubling since 1990. It is a major risk factor for numerous comorbidities, including hypertension, type 2 diabetes, cardiovascular disease, dementia, and an increased likelihood of developing cancer. Obesity is characterized by excessive adipose tissue expansion, with white adipose tissue (WAT) being the most extensively studied type. WAT plays a critical role in energy storage, endocrine regulation, and metabolic homeostasis, demonstrating remarkable plasticity by transitioning between progenitor and differentiated states. However, when adipocytes undergo excessive hypertrophy, they exhibit fibrosis, inflammation, and metabolic dysfunction, ultimately leading to insulin resistance and systemic disease. The extracellular matrix (ECM) plays a pivotal role in adipose tissue remodeling, but excessive ECM deposition in fibrotic tissue disrupts normal metabolic function. As obesity progresses, adipose tissue expansion is frequently accompanied by fibrosis and chronic low-grade inflammation, both of which exacerbate metabolic dysfunction and contribute to obesity-related complications. Fibrosis, marked by excessive ECM accumulation, alters adipose tissue architecture and impairs adipocyte function, leading to metabolic dysregulation. Simultaneously, inflammation—driven by immune cell infiltration and the release of pro-inflammatory cytokines—further disrupts tissue homeostasis and promotes systemic insulin resistance. Given these pathological changes, understanding the molecular mechanisms that govern adipose tissue remodeling in obesity is essential. One key protein implicated in these processes is aortic carboxypeptidase-like protein (ACLP), which has been linked to fibrotic remodeling in various tissues. ACLP plays a crucial role in ECM dynamics by regulating collagen deposition, fibroblast activation, and tissue stiffening—hallmarks of fibrosis. In the adipose tissue, ACLP may serve as a key mediator connecting obesity-induced mechanical and inflammatory cues to fibrotic remodeling. Investigating its role in adipose tissue fibrosis could provide valuable insights into the interplay between ECM remodeling, inflammation, and metabolic dysfunction. The molecular pathways that drive fibrosis and inflammation in adipose tissue are crucial for identifying potential therapeutic targets to mitigate obesity-related complications. By further studying ACLP’s role and its downstream signaling mechanisms, we may uncover novel strategies to alleviate fibrotic burden and enhance adipose tissue plasticity, ultimately improving metabolic health.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Vejar, Crystal Denise
- Advisors dc:contributor.advisor
-
- Layne, Matthew D.
- Pickering, Richard T.
Subjects
dc:subject × 9Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/52389